Trials / Recruiting
RecruitingNCT07329621
A Brain Imaging Study to Assess the Binding of MSP-2020 to Serotonin 5-HT2A Receptors in Healthy Male Adults
A Phase 1, Open-label, Positron Emission Tomography (PET) Trial to Measure Serotonin 5-HT2A Receptor Occupancy Following Single Oral Doses of MSP-2020 in Healthy Male Adults
- Status
- Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 18 (estimated)
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. · Industry
- Sex
- Male
- Age
- 23 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This study is to see how well MSP-2020 attaches to specific targets in the brain called serotonin type 2A receptors (5-HT2AR). This study will also look at how much of the study drug (and its metabolite) is in the blood and how long the study drug stays in the blood, as well as the safety of MSP 2020.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MSP-2020 | capsule |
Timeline
- Start date
- 2026-01-15
- Primary completion
- 2027-01-29
- Completion
- 2027-02-11
- First posted
- 2026-01-09
- Last updated
- 2026-02-27
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT07329621. Inclusion in this directory is not an endorsement.